Mycenax Biotech Inc. 4726.TWO Stock
Mycenax Biotech Inc. Price Chart
Mycenax Biotech Inc. 4726.TWO Financial and Trading Overview
| Mycenax Biotech Inc. stock price | 42.5 TWD |
| Previous Close | 41.2 TWD |
| Open | 41.6 TWD |
| Bid | 42.95 TWD x 0 |
| Ask | 43 TWD x 0 |
| Day's Range | 41.4 - 43.3 TWD |
| 52 Week Range | 32.9 - 55 TWD |
| Volume | 1.91M TWD |
| Avg. Volume | 849.95K TWD |
| Market Cap | 8.83B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.35 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4726.TWO Valuation Measures
| Enterprise Value | 8.57B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.8425994 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Mycenax Biotech Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 9.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 55 TWD |
| 52 Week Low | 32.9 TWD |
| 50-Day Moving Average | 39.4 TWD |
| 200-Day Moving Average | 39.08 TWD |
4726.TWO Share Statistics
| Avg. Volume (3 month) | 849.95K TWD |
| Avg. Daily Volume (10-Days) | 2.55M TWD |
| Shares Outstanding | 205.4M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 52.00% |
| % Held by Institutions | 0.042% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 4.43 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -115265000 TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -4.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 15.127 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Mycenax Biotech Inc.
| Country | Taiwan |
| State | N/A |
| City | Zhubei |
| Address | No. 66, Shengyi 2nd Road |
| ZIP | 302041 |
| Phone | 886 37 586 988 |
| Website | https://www.mycenax.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 387 |
Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services; GMP manufacturing services, such as drug substance and products manufacturing, and cell banking; and manufacturing technologies. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.
Q&A For Mycenax Biotech Inc. Stock
What is a current 4726.TWO stock price?
Mycenax Biotech Inc. 4726.TWO stock price today per share is 42.5 TWD.
How to purchase Mycenax Biotech Inc. stock?
You can buy 4726.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mycenax Biotech Inc.?
The stock symbol or ticker of Mycenax Biotech Inc. is 4726.TWO.
Which industry does the Mycenax Biotech Inc. company belong to?
The Mycenax Biotech Inc. industry is Biotechnology.
How many shares does Mycenax Biotech Inc. have in circulation?
The max supply of Mycenax Biotech Inc. shares is 205.73M.
What is Mycenax Biotech Inc. Price to Earnings Ratio (PE Ratio)?
Mycenax Biotech Inc. PE Ratio is now.
What was Mycenax Biotech Inc. earnings per share over the trailing 12 months (TTM)?
Mycenax Biotech Inc. EPS is -3.35 TWD over the trailing 12 months.
Which sector does the Mycenax Biotech Inc. company belong to?
The Mycenax Biotech Inc. sector is Healthcare.